Pierre-Marie is the Chief Executive Officer of the start-up Sinnovial, which is a biotechnology company created in September 2015 in partnership with Grenoble Alpes Hospital and University of Sciences. It is specialized in the development of innovative personalized medicine devices to improve the Chronic Inflammatory Rheumatism (CIR) management in rheumatology (especially rheumatoid arthritis and ankylosing spondylitis).
Sinnovial works towards these ends by providing its expertise and SinnoTest® technology (based on the analysis of patients’ proteomic profile and the calculation of treatment response probabilities ) to rheumatologists to contribute to the improvement of living conditions of people with Chronic Inflammatory Disease (CID).
The aim of SinnoTest® is to enable the physician to improve his patient management by maximizing successful biotherapy treatment from the initiation of the medical procedure.
PhD in Neuropharmacology (University Paris Descartes) and titular of a Master’s degree in Company Management (CNAM-International Institut of Management), Antony Lebeau has successively worked as research engineer (Inserm/Research Institut of Servier), project manager (GIS Prion-Ministry of Research, Inserm Transfert), communication manager (Inserm-Tranfert and Inserm-Transfert Initiative. He joined the French National Research Agency (ANR) as project manager in the of « Health Biology » department, working on Technology Transfer programs (RIB/Biotecs ,TecSan). He currently works as program officer in the ANR department of « Investments for the future and competitiveness », working in the field of public-private partnerships. Antony Lebeau has been also expert for the European Commission and for the ERC in « Health and Biotechnology » and « Ethic and Governance » fields for the past 8 years.
Rafi Mardachti is a Pharmacist (Pharm.D) from the University of Paris XI (France). He has an MBA from the Albany College of Pharmacy of Union University (USA). He is a Master of Pharmaceutical Marketing from the University of Paris XI (France). He is the winner of the National Thesis prize in 1995: Mail Order Pharmacy.
His previous positions were: Regional District Manager at MEDCO (USA), Pharmacist Manager at Marionnaud (France), Health Manager Director at Quintiles (Europe). He is the founder and CEO of Universal Medica.
Rafi Mardachti has published various articles in specialized media and teaches at various schools and specialized Master’s degrees.